Skip to content

Clinical trials

Phase 3 Migraine Disorders trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 3 Country / region: Poland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20151
20163
20192
20204
20215
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Teva Branded Pharmaceutical Products R&D, Inc.5
AbbVie4
Pfizer4
Amgen3
H. Lundbeck A/S3
Endo USA Inc., a Keenova Therapeutics Company1
Janssen Pharmaceutica N.V., Belgium1
Teva Branded Pharmaceutical Products R&D LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders22
Headache4
Hyperacusis3
Nausea3
Photophobia3
Headache Disorders1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.